Specifically, IL-1β has been previously associated with promoting CRC (12), and findings have shown a role for IL-1β in interacting with immune cells and supporting tumor progression (15) as well as invasiveness and resistance to certain chemotherapeutic agents (16). Here, IL1B is linked to neoplasm.